Page 529 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 32 Acquired Disorders of Red Cell, White Cell, and Platelet Production 444.e5

206. Bux J, Ernst-Schlegel M, Rothe B, et al: Neutropenia and anaemia due 217. Rouveix B, Lassoued K, Vittecoq D, et al: Neutropenia due to beta
to carbimazole-dependent antibodies. Br J Haematol 109:243, 2000. lactamine antibodies. Br Med J (Clin Res Ed) 287:1832, 1983.
207. Tamai H, Mukuta T, Matsubayashi S, et al: Treatment of methimazole- 218. Fumeaux Z, Beris P, Borisch B, et al: Complete remission of pure white
induced agranulocytosis using recombinant human granulocyte colony- cell aplasia associated with thymoma, autoimmune thyroiditis and type
stimulating factor (rhG-CSF). J Clin Endocrinol Metab 77:1356, 1993. 1 diabetes. Eur J Haematol 70:186, 2003.
208. Sato K, Miyakawa M, Han DC, et al: Graves’ disease with neutropenia 219. Krantz SB, Kao V: Studies on red cell aplasia. I. Demonstration of a
and marked splenomegaly: Autoimmune neutropenia due to propyl- plasma inhibitor to heme synthesis and an antibody to erythroblast
thiouracil. J Endocrinol Invest 8:551, 1985. nuclei. Proc Natl Acad Sci USA 58:493, 1967.
209. Curtis BR, Reno C, Aster RH: Neonatal alloimmune neutropenia 220. Schade AE, Wlodarski MW, Maciejewski JP: Pathophysiology defined
attributed to maternal immunoglobulin G antibodies against the by altered signal transduction pathways: The role of JAK-STAT and
neutrophil alloantigen HNA-1c (SH): A report of five cases. Transfusion PI3K signaling in leukemic large granular lymphocytes. Cell Cycle
45:1308, 2005. 5:2571, 2006.
210. Lalezari P, Murphy GB, Allen FH, Jr: NB1, a new neutrophil-specific 221. Semenzato G, Zambello R, Starkebaum G, et al: The lymphoprolifera-
antigen involved in the pathogenesis of neonatal neutropenia. J Clin tive disease of granular lymphocytes: Updated criteria for diagnosis.
Invest 50:1108, 1971. Blood 89:256, 1997.
211. Lalezari P: Neutrophil antigens: Immunology and clinical implications. 222. Mason KD, Carpinelli MR, Fletcher JI, et al: Programmed anuclear cell
Prog Clin Biol Res 13:209, 1977. death delimits platelet life span. Cell 128:1173, 2007.
212. Lamy T, Loughran TP, Jr: Clinical features of large granular lymphocyte 223. Dale GL, Friese P: Bax activators potentiate coated-platelet formation.
leukemia. Semin Hematol 40:185, 2003. J Thromb Haemost 4:2664, 2006.
213. Rose MG, Berliner N: T-cell large granular lymphocyte leukemia and 224. Kaluzhny Y, Yu G, Sun S, et al: BclxL overexpression in megakaryocytes
related disorders. Oncologist 9:247, 2004. leads to impaired platelet fragmentation. Blood 100:1670, 2002.
214. Lamy T, Loughran TP, Jr: Current concepts: Large granular lymphocyte 225. Beer JH, Buchi L, Steiner B: Glycocalicin: A new assay—-the normal
leukemia. Blood Rev 13:230, 1999. plasma levels and its potential usefulness in selected diseases. Blood
215. Aref SE, Mahmoud LA, El Refie MF, et al: Assessment of neutrophil 83:691, 1994.
apoptosis ex vivo in hepatosplenic patients with neutropenia pre and 226. Kojima K, Fujii N, Omoto E, et al: Cyclic thrombocytopenia and
post splenectomy. Hematology 8:265, 2003. polycythemia vera. Ann Hematol 82:61, 2003.
216. Weitzman SA, Stossel TP: Drug-induced immunological neutropenia. 227. Menitove JE, Pereira J, Hoffman R, et al: Cyclic thrombocytopenia of
Lancet 1:1068, 1978. apparent autoimmune etiology. Blood 73:1561, 1989.